Ifakara Health Institute is taking part in the 20th edition of the International Conference on HIV Treatment, Pathogenesis, and Prevention Research (INTEREST) 2026, taking place from 12–15 May 2026 at the Julius Nyerere International Convention Centre (JNICC) in Dar es Salaam, Tanzania. The conference is organized by Virology Education B.V.

INTEREST 2026 brings together researchers, healthcare professionals, policymakers, and partners from across Africa and beyond to discuss the latest advancements in HIV diagnosis, treatment, and prevention. This year’s conference continues to emphasize the importance of strengthening African-led research and fostering collaboration to support locally relevant solutions for managing HIV-1 infection and preventing transmission.

At the conference, several Ifakara staff members are participating through poster presentations, scientific discussions, and engagement in various conference sessions and networking opportunities. Their participation reflects Ifakara’s continued commitment to advancing research and contributing to efforts aimed at improving public health outcomes across the region.

The conference also provides an important platform for sharing knowledge, building partnerships, and exploring innovative approaches to addressing the evolving challenges of HIV prevention and care.

Beyond HIV and TB: Ifakara talks malaria

Ifakara’s Director of Science, Dr Ally Olotu, participated in a session on eliminating malaria in Africa, highlighting key interventions, progress made across the continent, and emerging technologies such as vaccines in the fight against the disease.

For more information and to view the full Programme 2026, please visit the official INTEREST Conference website